AAP
BBNX

Arax Advisory Partners’s Beta Bionics BBNX Stock Holding History

Arax Advisory Partners’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.1K Buy
+6,262
New +$74.5K ﹤0.01% 2746
2026
Q1 		– Sell
-45
Closed -$1.37K – 4447
2025
Q4 		$1.37K Sell
45
-880
-95% -$23.5K ﹤0.01% 3400
2025
Q3 		$18.4K Buy
925
+895
+2,983% +$15.7K ﹤0.01% 2302
2025
Q2 		$437 Buy
+30
New +$425 ﹤0.01% 2939

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Arax Advisory Partners's BBNX Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Beta Bionics (BBNX) in Q2 2026: 6,262 shares worth $98.1K. The stake represents ﹤0.01% of the portfolio and ranks #2746 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in BBNX as recently as Q4 2025.

Arax Advisory Partners first reported a position in BBNX in Q2 2025 and has held it in 4 quarters since. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Arax Advisory Partners held 6,262 shares of Beta Bionics worth $98.1K as of Q2 2026.
  • Beta Bionics was a new Arax Advisory Partners position in Q2 2026.
  • Beta Bionics made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2746 holding.
  • Arax Advisory Partners first reported a position in Beta Bionics in Q2 2025 and has held it in 4 quarters since.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.